1887

Chapter 27 : Cryopreservation of Peripheral Blood Mononuclear Cells

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Cryopreservation of Peripheral Blood Mononuclear Cells, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH27-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH27-2.gif

Abstract:

The utility of cryopreserved peripheral blood mononuclear cells (PBMC) in clinical and diagnostic immunology is widely recognized. The use of cryopreserved PBMC offers multiple advantages for studies. The ability to batch specimens permits significant cost reductions through efficient utilization of labor and reagents and permits testing of multiple samples in a single run, thus avoiding interassay variability and providing more meaningful comparisons in longitudinal studies.

Citation: Weinberg A. 2016. Cryopreservation of Peripheral Blood Mononuclear Cells, p 263-268. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch27
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

CMV-specific RCF in cryopreserved versus fresh PBMC from HIV-infected patients and uninfected controls. Data were derived from samples from HIV-infected patients (HIV+, triangles) and uninfected controls (HIV−, squares). The diagonal represents the slope of equivalence between fresh- and frozen-cell assays.

Citation: Weinberg A. 2016. Cryopreservation of Peripheral Blood Mononuclear Cells, p 263-268. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch27
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Effect of viability on cryopreserved PBMC LPA results. Data were derived from samples from HIV-infected patients. The panels on the left show that when analyzing all samples, the LPA results significantly increase with higher viability. A breakpoint in the distribution pattern can be observed at a viability of 70%. The panels on the right show that when analyzing only samples with a viability of ≥70%, the LPA results are independent of the PBMC viability. SI, stimulation index.

Citation: Weinberg A. 2016. Cryopreservation of Peripheral Blood Mononuclear Cells, p 263-268. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch27
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

CMV-specific IFN-γ in cryopreserved versus fresh PBMC from HIV-infected patients (triangles) and controls (squares). Data were derived from samples from HIV-infected patients and uninfected controls. The diagonal represents the slope of equivalence between fresh- and frozen-cell assays.

Citation: Weinberg A. 2016. Cryopreservation of Peripheral Blood Mononuclear Cells, p 263-268. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch27
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Effect of cryopreservation on flow cytometric immunophenotyping. Data were derived from samples from HIV-infected subjects (triangles) and controls (squares). The diagonal represents the slope of equivalence between fresh- and frozen-cell assays. (A) Example of a cell surface marker that is well preserved during cryopreservation (CD95). (B) Loss of CD62L during cryopreservation.

Citation: Weinberg A. 2016. Cryopreservation of Peripheral Blood Mononuclear Cells, p 263-268. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch27
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818722.ch27
1. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112116.[PubMed].[CrossRef]
2. Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, McElrath MJ. 2007. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 322:5769.[CrossRef].[PubMed]
3. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, Giorgi JV. 1999. Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in multicenter study. Clin Diagn Lab Immunol 6:1419.[PubMed]
4. Weinberg A, Betensky R, Zhang L, Ray G. 1998. Effect of shipment, storage, anticoagulant and cell separation on lymphoproliferative responses in HIV-infected patients. Clin Diagn Lab Immunol 5:804807.[PubMed]
5. Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, Craddock JA, Liu H, Martinez CA, Kennedy-Nasser A, Leung KS, Gottschalk SM, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM. 2013. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther 21:21132121.[CrossRef].[PubMed]
6. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereux P, Durand D, Riedel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E, Fenton T Pediatric ACTG Cryopreservation Group. 2009. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T cell characterization. Clin Vaccine Immunol 16:11761186.[CrossRef].[PubMed]
7. Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD, Carter D, Defawe OD, Garcia A, Gerrelts TL, Gelman R, Lambrecht LK, Pahwa S, Pilakka-Kanthikeel S, Shugarts DL, Tustin NB. 2010. Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. J Immunol Methods 363:4250.[CrossRef].[PubMed]
8. Weinberg A, Wohl DA, Brown DG, Pott GB, Zhang L, Ray MG, van der Horst C. 2000. Effect of cryopreservation on measurement of cytomegalovirus-specific cellular immune responses in HIV-infected patients. J Acquir Immune Defic Syndr 25:109114.[PubMed].[CrossRef]
9. Weinberg A, Zhang L, Brown D, Erice A, Polsky B, Hirsch MS, Owens S, Lamb K ACTG Team 360. 2000. Viability and functional activity of cryopreserved mononuclear cells. Clin Diagn Lab Immunol 7:714716.[PubMed]
10. Smith JG, Joseph HR, Green T, Field JA, Wooters M, Kaufhold RM, Antonello J, Caulfield MJ. 2007. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin Vaccine Immunol 14:527537.[CrossRef].[PubMed]
11. Hviid L, Albeck G, Hansen B, Theander TG, Talbot A. 1993. A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells. J Immunol Methods 157:135142.[PubMed].[CrossRef]
12. Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, Payne JK, Kuus-Reichel K, Chang JC, Summers A, Clay TM, Morse MA, Lyerly HK, DeLaRosa C, Ankerst DP, Disis ML. 2005. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol 6:17.[CrossRef].[PubMed]
13. Mata MM, Mahmood F, Sowell RT, Baum LL. 2014. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. J Immunol Methods 406:19.[CrossRef].[PubMed]
14. Reimann KA, Chernoff M, Wilkening C, Nickerson C, Landay A ACTG Immunology Advanced Technology Laboratories. 2000. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from HIV-1-infected donors: implications for multicenter clinical trials. Clin Diagn Lab Immunol 7:352359.[PubMed]
15. Sleasman JW, Leon BH, Aleixo LF, Rojas M, Goodenow MM. 1997. Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation. Clin Diagn Lab Immunol 4:653658.[PubMed]
16. Ventakaraman M. 1992. Cryopreservation-induced enhancement of interleukin-2 production in human peripheral blood mononuclear cells. Cryobiology 29:165174.[CrossRef]
17. Aziz N, Margolick JB, Detels R, Rinaldo CR, Phair J, Jamieson BD, Butch AW. 2013. Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study. Clin Vaccine Immunol 20:590595.[CrossRef].[PubMed]
18. Boaz MJ, Hayes P, Tarragona T, Seamons L, Cooper A, Birungi J, Kitandwe P, Semaganda A, Kaleebu P, Stevens G, Anzala O, Farah B, Ogola S, Indangasi J, Mhlanga P, Van Eeden M, Thakar M, Pujari A, Mishra S, Goonetilleke N, Moore S, Mahmoud A, Sathyamoorthy P, Mahalingam J, Narayanan PR, Ramanathan VD, Cox JH, Dally L, Gill DK, Gilmour J. 2009. Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents. Clin Vaccine Immunol 16:147155.[CrossRef].[PubMed]
19. Ducar C, Smith D, Pinzon C, Stirewalt M, Cooper C, McElrath MJ, Hural J. 2014. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal. J Immunol Methods 409:920.[CrossRef].[PubMed]
20. Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S, Kijak GH, Roederer M, Levine G, D'Souza MP, Jaimes M, Koup R, Denny T, Cox J, Ferrari G. 2014. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. J Immunol Methods 409:107116.[CrossRef].[PubMed]
21. Sanchez AM, Rountree W, Berrong M, Garcia A, Schuetz A, Cox J, Frahm N, Manak M, Sarzotti-Kelsoe M, D'Souza MP, Denny T, Ferrari G. 2014. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-gamma ELISpot) assay. J Immunol Methods 409:3143.[CrossRef].[PubMed]
22. Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, Ferrari G, Stevens WS, Stager SL, Binz W, Louzao R, Long KO, Mokgotho P, Moodley N, Mackay M, Kerkau M, McMillion T, Kirchherr J, Soderberg KA, Haynes BF, Denny TN. 2014. The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells. J Immunol Methods 409:2130.[CrossRef].[PubMed]
23. Staats JS, Enzor JH, Sanchez AM, Rountree W, Chan C, Jaimes M, Chan RC, Gaur A, Denny TN, Weinhold KJ. 2014. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays. J Immunol Methods 409:4453.[CrossRef].[PubMed]
24. Weinberg A, Louzao R, Mussi-Pinhata MM, Cruz ML, Pinto JA, Huff MF, de Castro AC, Sucupira MC, Denny TW. 2007. Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin Vaccine Immunol 14:12421244.[CrossRef].[PubMed]
25. Horton H, Thomas EP, Stucky JA, Frank I, Moodie Z, Huang Y, Chiu YL, McElrath MJ, De Rosa SC. 2007. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J Immunol Methods 323:3954.[CrossRef].[PubMed]

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error